Titles

Professor of Pharmaceutical Sciences

School Affiliation

School of Pharmacy

Specialties

• Entrepreneurism
• Medical Cannabis Education
• Regulatory Affairs

About

410-706-6710 neddingt@rx.umaryland.edu

Dr. Eddington became dean of the School of Pharmacy (SOP) in August 2007. An alumna of the school, she was formerly chair of its Department of Pharmaceutical Sciences. Dr. Eddington graduated summa cum laude with a bachelor’s degree in pharmacy from Howard University. She later earned her PhD from SOP and, after working as assistant director of new drug development at Pfizer Inc., joined the faculty in 1991. She was appointed director of SOP’s Pharmacokinetics/Biopharmaceutics Laboratory in 1999 and became chair of the Department of Pharmaceutical Sciences in 2003. As chair, she guided the launch of the Bio- and Nano-Technology Center, which brings together scientists to find new and better ways of providing pharmaceutical treatment. It was SOP’s first organized research center. Dr. Eddington is a nationally known expert in drug delivery and pharmacokinetics, the movement of drugs in the body. Her research focuses on cancer therapy and treatments for disorders of the central nervous system. Her work has been supported by funding from the National Cancer Institute, the National Institute of Mental Health, the National Institute on Drug Abuse, the Food and Drug Administration (FDA), and the pharmaceutical industry. In 2014, she was named executive director of University Regional Partnerships at UMB, a position she assumes while maintaining her leadership of SOP. In this role, Dr. Eddington assists UMB’s senior leadership, working collaboratively with the deans on issues related to the expansion of the University’s academic and research programs in Montgomery and Prince George’s counties. In 2017, she was appointed co-decanal lead of the Center for Addiction Research, Education, and Service (CARES), UMB’s interprofessional effort to address the adverse impact of addiction on individuals, families, communities, and society. Under Dr. Eddington’s leadership, SOP has established a number of centers and programs including the Center for Innovative Pharmacy Solutions; the Patients, Pharmacists, Partnerships (P3) Program; the Patient-centered Involvement in Evaluating the effectiveness of Treatment (PATIENTS) Program; the Bio- and Nano-Technology Center; the Center for Translational Medicine; the Mass Spectrometry Center; and the FDA-supported Maryland Center of Excellence in Regulatory Science and Innovation, a collaborative agreement with the FDA to promote innovation in support of the development and evaluation of safe and effective products. She also has envisioned and launched a transformational pharmapreneurism initiative, which seeks to position the school’s world-class faculty, wonderful students, and exceptional staff to achieve their career aspirations and address our nation’s health care, research, policy, and societal needs.

Read a longer bio.

For interview requests, please contact the Office of Communications and Public Affairs.

Tagged: The Future of Health Care   Caring for the Human Condition   Economic Development  

This information was last updated January 9, 2024.